Hepatoblastoma
Conditions
Interventions
Case series:HIFU+TACE
Sponsors
Children's Hospital of Chongqing Medical University
Eligibility
Sex/Gender
All
Age
No minimum to 18 Years
Inclusion criteria
Inclusion criteria: Un-resectionable hepatoblastoma which were classified by PRETEXT system as stage III and IV, and no metastasis at the primary administration.
Exclusion criteria
Exclusion criteria: Allegery to Iodine contrast agent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| AFP;tumor size;2 year overall survival; | — |
Countries
China
Contacts
Public ContactShan Wang
Children's Hospital of Chongqing Medical University
Outcome results
None listed